Jae Ik Jung
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jae Ik Jung has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Dong Rak Kwon
Department of Rehabilitation Medicine, School of Medicine, Daegu Catholic University
2 shared publications - Byeong-Churl Jang
Department of Molecular Medicine, College of Medicine, Keimyung University, 1095 Dalgubeoldaero, Dalseo-gu, Daegu 42601, Republic of Korea
1 shared publication - Eun Sang Kwon
Department of Medicine, College of Medicine, Keimyung University, Daegu 42601, Republic of Korea
1 shared publication - Gi-Young Park
Department of Rehabilitation Medicine, Daegu Catholic University School of Medicine, Nam-Gu, Daegu 42472, Republic of Korea
1 shared publication - Hee Kyung Cho
Department of Physical Medicine and Rehabilitation, Catholic University of Daegu School of Medicine, Daegu, Republic of Korea
1 shared publication - Kang Lip Kim
Department of Physical Medicine and Rehabilitation, Daegu Health College Hospital, Daegu, Republic of Korea
1 shared publication
Latest Publications
- Open Access
- 1 April 2025
- Published by Joint Diseases and Related Surgery in Joint Diseases and Related Surgery
- Vol. 36 (2) , 461-466
Ultrasound-guided nerve hydrodissection for sciatic neuropathy caused by piriformis rhabdomyolysis: A case report
Joint Diseases and Related Surgery (JDRS), the official journal of the Turkish Joint Diseases Foundation, is an international, peer-reviewed, immediate open access journal. All published articles in JDRS has been free for everyone, without embargo, since 1990.
- 1 April 2025
- Published by Joint Diseases and Related Surgery in Joint Diseases and Related Surgery
- Vol. 36 (2) , 461-466
Open AccessUltrasound-guided nerve hydrodissection for sciatic neuropathy caused by piriformis rhabdomyolysis: A case report
Joint Diseases and Related Surgery (JDRS), the official journal of the Turkish Joint Diseases Foundation, is an international, peer-reviewed, immediate open access journal. All published articles in JDRS has been free for everyone, without embargo, since 1990.
- Open Access
- 21 January 2025
- Published by Yeungnam University College of Medicine in Journal of Yeungnam Medical Science
- Vol. 42, 23
Unilateral lower extremity lymphedema followed by COVID-19 vaccination in patients with cervical cancer history: two case reports
The coronavirus disease 2019 (COVID-19) pandemic prompted the development of messenger RNA vaccines. Following extensive vaccination campaigns worldwide, several adverse reactions to these vaccines have been reported. This is a case series of unilateral lower extremity lymphedema after COVID-19 vaccination in two patients with a history of cervical cancer. An 82-year-old woman and a 68-year-old woman visited the outpatient clinic with unilateral leg edema after receiving a COVID-19 booster vaccine (BNT162b2; Pfizer-BioNTech) in the deltoid muscle. Both patients had a common history of cervical cancer treated with surgery, chemotherapy, and radiotherapy and were in complete remission. Gynecological evaluations, including laboratory and imaging studies, revealed no specific findings. Lymphoscintigraphy revealed delayed lymphatic drainage with diffuse dermal backflow in a unilateral lower extremity. This case series explores adverse reactions to COVID-19 vaccination in patients who are at high risk of developing lymphedema, providing novel data for similar clinical presentations.
- 21 January 2025
- Published by Yeungnam University College of Medicine in Journal of Yeungnam Medical Science
- Vol. 42, 23
Open AccessUnilateral lower extremity lymphedema followed by COVID-19 vaccination in patients with cervical cancer history: two case reports
The coronavirus disease 2019 (COVID-19) pandemic prompted the development of messenger RNA vaccines. Following extensive vaccination campaigns worldwide, several adverse reactions to these vaccines have been reported. This is a case series of unilateral lower extremity lymphedema after COVID-19 vaccination in two patients with a history of cervical cancer. An 82-year-old woman and a 68-year-old woman visited the outpatient clinic with unilateral leg edema after receiving a COVID-19 booster vaccine (BNT162b2; Pfizer-BioNTech) in the deltoid muscle. Both patients had a common history of cervical cancer treated with surgery, chemotherapy, and radiotherapy and were in complete remission. Gynecological evaluations, including laboratory and imaging studies, revealed no specific findings. Lymphoscintigraphy revealed delayed lymphatic drainage with diffuse dermal backflow in a unilateral lower extremity. This case series explores adverse reactions to COVID-19 vaccination in patients who are at high risk of developing lymphedema, providing novel data for similar clinical presentations.
- Open Access
- 13 December 2024
- Published by Wolters Kluwer Health in Medicine
- Vol. 103 (50) , e40877
The effectiveness of care robots in alleviating physical burden and pain for caregivers: Non-randomized prospective interventional study – Preliminary study
Background: Caregiver burden significantly affects both patients and caregivers but is often overlooked in clinical practice. Physical and emotional strain on caregivers can compromise the quality of care. Care robots are emerging as solutions to alleviate these burdens by assisting with routine tasks, thereby reducing caregivers’ physical strain and stress. Therefore, a prospective, non-randomized, interventional clinical trial was designed to identify changes in caregivers’ physical activities due to care robot use and explore the associated benefits. Methods: Twenty-two caregivers (1 male and 21 female; mean age, 62.05 years) were participated. We analyzed the impact of care robots on reducing physical burden and assessed caregivers’ satisfaction with these robots by examining care activity history, pain levels, muscle activities, and data for each physical care activity (e.g., transfer, reposition, feeding, and toileting), categorizing them based on whether a care robot was used. Care robots that assist in transfer, repositioning, feeding, and toileting activities were used in a clinical trial. Muscle activity was measured during maximum voluntary isometric contraction using electromyography sensors placed on the upper trapezius, biceps brachii, and erector spinae muscles. Results: During care robot use, we observed a statistically significant decrease in the distance and number of steps required for assisting with repositioning. However, the caregiving activity time increased when the robots assisted with transfer, feeding, and toileting (P < .001). Pain was significantly reduced during transfer and toileting activities using the care robot (P < .001) as well as during feeding activity (P = .040). Maximum voluntary isometric contraction showed a significant reduction in the upper trapezius, biceps brachii, and erector spinae muscles during the 4 care activities when using the robot, and these findings were consistent across the 3 sessions (P < .001). In the survey, caregivers indicated that “transfer-assisting” care robots were the most needed (15 respondents, 68.2%). Conclusion: In this study, we demonstrated that employing care robots can aid in mitigating muscle overuse among caregivers, potentially alleviating pain due to musculoskeletal conditions.
- 13 December 2024
- Published by Wolters Kluwer Health in Medicine
- Vol. 103 (50) , e40877
Open AccessThe effectiveness of care robots in alleviating physical burden and pain for caregivers: Non-randomized prospective interventional study – Preliminary study
Background: Caregiver burden significantly affects both patients and caregivers but is often overlooked in clinical practice. Physical and emotional strain on caregivers can compromise the quality of care. Care robots are emerging as solutions to alleviate these burdens by assisting with routine tasks, thereby reducing caregivers’ physical strain and stress. Therefore, a prospective, non-randomized, interventional clinical trial was designed to identify changes in caregivers’ physical activities due to care robot use and explore the associated benefits. Methods: Twenty-two caregivers (1 male and 21 female; mean age, 62.05 years) were participated. We analyzed the impact of care robots on reducing physical burden and assessed caregivers’ satisfaction with these robots by examining care activity history, pain levels, muscle activities, and data for each physical care activity (e.g., transfer, reposition, feeding, and toileting), categorizing them based on whether a care robot was used. Care robots that assist in transfer, repositioning, feeding, and toileting activities were used in a clinical trial. Muscle activity was measured during maximum voluntary isometric contraction using electromyography sensors placed on the upper trapezius, biceps brachii, and erector spinae muscles. Results: During care robot use, we observed a statistically significant decrease in the distance and number of steps required for assisting with repositioning. However, the caregiving activity time increased when the robots assisted with transfer, feeding, and toileting (P < .001). Pain was significantly reduced during transfer and toileting activities using the care robot (P < .001) as well as during feeding activity (P = .040). Maximum voluntary isometric contraction showed a significant reduction in the upper trapezius, biceps brachii, and erector spinae muscles during the 4 care activities when using the robot, and these findings were consistent across the 3 sessions (P < .001). In the survey, caregivers indicated that “transfer-assisting” care robots were the most needed (15 respondents, 68.2%). Conclusion: In this study, we demonstrated that employing care robots can aid in mitigating muscle overuse among caregivers, potentially alleviating pain due to musculoskeletal conditions.
- Open Access
- 5 May 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (9) , 5035
Comparison of Muscle Regeneration Effects at Different Melittin Concentrations in Rabbit Atrophied Muscle
This research aimed to explore the healing impacts of Melittin treatment on gastrocnemius muscle wasting caused by immobilization with a cast in rabbits. Twenty-four rabbits were randomly allocated to four groups. The procedures included different injections: 0.2 mL of normal saline to Group 1 (G1-NS); 4 μg/kg of Melittin to Group 2 (G2-4 μg/kg Melittin); 20 μg/kg of Melittin to Group 3 (G3-20 μg/kg Melittin); and 100 μg/kg of Melittin to Group 4 (G4-100 μg/kg Melittin). Ultrasound was used to guide the injections into the rabbits’ atrophied calf muscles following two weeks of immobilization via casting. Clinical measurements, including the length of the calf, the compound muscle action potential (CMAP) of the tibial nerve, and the gastrocnemius muscle thickness, were assessed. Additionally, cross-sectional slices of gastrocnemius muscle fibers were examined, and immunohistochemistry and Western blot analyses were performed following two weeks of therapy. The mean regenerative changes, as indicated by clinical parameters, in Group 4 were significantly more pronounced than in the other groups (p < 0.05). Furthermore, the cross-sectional area of the gastrocnemius muscle fibers and immunohistochemical indicators in Group 4 exceeded those in the remaining groups (p < 0.05). Western blot analysis also showed a more significant presence of anti-inflammatory and angiogenic cytokines in Group 4 compared to the others (p < 0.05). Melittin therapy at a higher dosage can more efficiently activate regeneration in atrophied gastrocnemius muscle compared to lower doses of Melittin or normal saline.
- 5 May 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (9) , 5035
Open AccessComparison of Muscle Regeneration Effects at Different Melittin Concentrations in Rabbit Atrophied Muscle
This research aimed to explore the healing impacts of Melittin treatment on gastrocnemius muscle wasting caused by immobilization with a cast in rabbits. Twenty-four rabbits were randomly allocated to four groups. The procedures included different injections: 0.2 mL of normal saline to Group 1 (G1-NS); 4 μg/kg of Melittin to Group 2 (G2-4 μg/kg Melittin); 20 μg/kg of Melittin to Group 3 (G3-20 μg/kg Melittin); and 100 μg/kg of Melittin to Group 4 (G4-100 μg/kg Melittin). Ultrasound was used to guide the injections into the rabbits’ atrophied calf muscles following two weeks of immobilization via casting. Clinical measurements, including the length of the calf, the compound muscle action potential (CMAP) of the tibial nerve, and the gastrocnemius muscle thickness, were assessed. Additionally, cross-sectional slices of gastrocnemius muscle fibers were examined, and immunohistochemistry and Western blot analyses were performed following two weeks of therapy. The mean regenerative changes, as indicated by clinical parameters, in Group 4 were significantly more pronounced than in the other groups (p < 0.05). Furthermore, the cross-sectional area of the gastrocnemius muscle fibers and immunohistochemical indicators in Group 4 exceeded those in the remaining groups (p < 0.05). Western blot analysis also showed a more significant presence of anti-inflammatory and angiogenic cytokines in Group 4 compared to the others (p < 0.05). Melittin therapy at a higher dosage can more efficiently activate regeneration in atrophied gastrocnemius muscle compared to lower doses of Melittin or normal saline.